US Patent 7977489 Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
Patent 7977489 was granted and assigned to Exelixis on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+158 characters)
Article
Patent abstract
Compounds of the following general structure for use in compositions and methods for modulating the activity of nuclear receptors are provided:
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07977489 Benzylthiazolone inhibitors of estrogen-related receptors (ERR) US Patent 7977489 Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
Infobox
Patent Number
0797748900
Patent Number
797748900
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079774890
Date of Patent
July 12, 2011
0Patent Application Number
115776110
Date Filed
October 21, 2005
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079774890
Date of Patent
July 12, 2011
0Patent Application Number
115776110
Date Filed
October 21, 2005
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07977489 Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07977489
Date of patent
July 12, 2011
Patent application number
11577611
Date Filed
October 21, 2005
Patent primary examiner
Find more entities like US Patent 7977489 Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.